Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 18
Phase 21
Phase 33
Phase 41

Trial Status

Completed10
Terminated2

Role Distribution

Other Roles12

Activity Timeline

Clinical Trials (12)

NCT04111965Phase 1/2Completed
Clinical Trial to Compare the Safety and Efficacy of Nanodrop®
Dry Eye
StudydirectorStart date: 2020-12-01
NCT03697876Phase 1Completed
Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel
Dry Eye Syndromes
StudydirectorStart date: 2018-08-20
NCT03519516Phase 1Completed
Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects
ConjunctivitisConjunctivitis, Bacterial
StudydirectorStart date: 2018-01-25
NCT03521791Phase 4Completed
Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.
Ocular InflammationOcular PainPost-surgical Inflammation+1 more
StudydirectorStart date: 2017-12-13
NCT03520348Phase 1Completed
Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.
Dry EyeDry Eye Syndrome of Unspecified Lacrimal Gland
StudydirectorStart date: 2017-10-04

Showing 10 of 12 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT04111965Phase 1/2StudyDirector

Clinical Trial to Compare the Safety and Efficacy of Nanodrop®

Dry Eye
Completed
NCT04081610Phase 1StudyDirector

Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution

Dry Eye
Completed
NCT03966365Phase 1StudyDirector

Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®

Glaucoma
Completed
NCT03965052Phase 1StudyDirector

Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

Glaucoma
Completed
NCT03693989Phase 3StudyDirector

Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification

Cataract
Completed
NCT03696342Phase 3StudyDirector

Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.

Conjunctivitis, Bacterial
Terminated
NCT03697876Phase 1StudyDirector

Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel

Dry Eye Syndromes
Completed
NCT03519516Phase 1StudyDirector

Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects

ConjunctivitisConjunctivitis, Bacterial
Completed
NCT03521791Phase 4StudyDirector

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.

Ocular InflammationOcular PainPost-surgical Inflammation+1 more
Completed
NCT03520348Phase 1StudyDirector

Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.

Dry EyeDry Eye Syndrome of Unspecified Lacrimal Gland
Completed
NCT03524157Phase 1StudyDirector

Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects

Dry Eye SyndromesLubricant AllergyTear Disorder
Completed
NCT02801617Phase 3StudyDirector

Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension

Ocular HypertensionPrimary Open Angle Glaucoma
Terminated

All 12 trials loaded